Hormone Use in Menopause and Male Andropause : A Choice for Women and Men: A Choice for Women and Men (Google eBook)

Front Cover
Oxford University Press, Oct 4, 2003 - Medical - 224 pages
0 Reviews
This book, by two of the most distinguished figures in fertility and reproduction research, answers all the most common questions about menaupause and andropause, and hormone resupplement therapy (HRT) for menopausal women. It offers explanations of all aspects of this subject, presenting balanced and reliable information about benefits, risks, and prospects for this field. Segal invented Norplant, the first long-term implantable contraceptive, and as the leader of Reproductive Biology at the Population Council, he orchestrated and coordinated the research and trials leading to basically every new contraceptive introduced over a period of about 25 years. Mastroianni did more than anyone else to develop in vitro fertizilation as a viable treatment option, and was for many years the chairman of the largest department of obstetrics and gynecology, and the director of the most successful IVF clinic. This book is unique in including coverage of the climacteric in men.
  

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Why do women have menopause?
3
What are the signs of menopause?
9
What is menopausal hormone therapy?
14
Why should women consider hormone therapy?
20
Riskbenefit ratio Making the choice
25
Can HT protect brain function and prevent Alzheimers disease?
38
Does the approach of menopause mean the end of fertility?
44
Herbal products for menopause
50
Why should men consider androgen supplementation therapy?
90
What are the AST choices for men?
97
The first designer androgen for men
104
Can men safely use AST?
109
Should aging men use nonprescription androgens?
115
Sex and the aging man
121
Can AST help brain function in aging men?
126
Questions about menopause
133

Can phytoestrogens antioxidants and vitamins replace HT?
58
Sex and the aging woman
63
What is the status of designer estrogens?
70
Is there a male menopause?
79
Is testosterone the only androgen the body produces?
85
Questions about andropause
148
Glossary of terms
157
References
165
Index
191
Copyright

Common terms and phrases

Popular passages

Page 170 - Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Page 171 - Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med.
Page 170 - Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
Page 170 - Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial.
Page 173 - Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S. Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001 ;345: 1 243-9 Vittinghoff E, Shilpak MG, Varosy PD, et al.

Bibliographic information